These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6389955)

  • 1. Idiopathic hypercalciuria associated with hyperreninemia and high urinary prostaglandin E.
    Houser M; Zimmerman B; Davidman M; Smith C; Sinaiko A; Fish A
    Kidney Int; 1984 Aug; 26(2):176-82. PubMed ID: 6389955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of prostaglandins in Bartter's syndrome.
    Winterborn MH; Hewitt GJ; Mitchell MD
    Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bartter's syndrome with normal urinary excretion of prostaglandin E: therapeutic effects of propranolol, spironolactone, indomethacin and potassium chloride.
    Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Yoshinaga K; Saito T; Kabuki J
    Tohoku J Exp Med; 1980 Jun; 131(2):151-9. PubMed ID: 7404582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin synthetase inhibitors in Bartter's syndrome. Effect on immunoreactive prostaglandin E excretion.
    Bowden RE; Gill JR; Radfar N; Taylor AA; Keiser HR
    JAMA; 1978 Jan; 239(2):117-21. PubMed ID: 412983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
    Halushka PV; Wohltmann H; Privitera PJ; Hurwitz G; Margolius HS
    Ann Intern Med; 1977 Sep; 87(3):281-6. PubMed ID: 900671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide.
    Nüsing RM; Reinalter SC; Peters M; Kömhoff M; Seyberth HW
    Clin Pharmacol Ther; 2001 Oct; 70(4):384-90. PubMed ID: 11673754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical variants of idiopathic hypercalciuria in children].
    Kohout I; Bachmann H
    Monatsschr Kinderheilkd; 1987 Dec; 135(12):847-50. PubMed ID: 3325840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium homeostasis and hypercalciuria in hyperprostaglandin E syndrome.
    Leonhardt A; Timmermanns G; Roth B; Seyberth HW
    J Pediatr; 1992 Apr; 120(4 Pt 1):546-54. PubMed ID: 1340758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of urinary prostaglandins in Bartter's syndrome.
    Zipser RD; Rude RK; Zia PK; Fichman MP
    Am J Med; 1979 Aug; 67(2):263-7. PubMed ID: 463932
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypercalciuria with Bartter syndrome: evidence for an abnormality of vitamin D metabolism.
    Restrepo de Rovetto C; Welch TR; Hug G; Clark KE; Bergstrom W
    J Pediatr; 1989 Sep; 115(3):397-404. PubMed ID: 2671327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion rate of 6-keto-prostaglandin F1 alpha as an index of circulating prostacyclin.
    Seyberth HW; Müller H; Soeding K; Wille L; Hackenthal E
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():533-8. PubMed ID: 6221575
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostaglandin E excretion and inhibition of prostaglandin synthesis in Bartter's syndrome.
    Hsieh BS; Chen WY; Yen TS; Lai MS
    Taiwan Yi Xue Hui Za Zhi; 1978 Nov; 77(11):831-8. PubMed ID: 284093
    [No Abstract]   [Full Text] [Related]  

  • 13. Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome.
    Seyberth HW; Rascher W; Schweer H; Kühl PG; Mehls O; Schärer K
    J Pediatr; 1985 Nov; 107(5):694-701. PubMed ID: 3863906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
    Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K
    Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostaglandins and aspirin therapy in Bartter's syndrome.
    Norby L; Flamenbaum W; Lentz R; Ramwell P
    Lancet; 1976 Sep; 2(7986):604-6. PubMed ID: 61344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders.
    Seyberth HW; Königer SJ; Rascher W; Kühl PG; Schweer H
    Pediatr Nephrol; 1987 Jul; 1(3):491-7. PubMed ID: 3153322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioimmunoassay of urinary prostaglandins E (proceedings)].
    Benzoni D; Vincent M; Jarsaillon E; Sassard J
    J Urol Nephrol (Paris); 1978 Sep; 84(9):679. PubMed ID: 748592
    [No Abstract]   [Full Text] [Related]  

  • 18. Familial Bartter's syndrome: report of a case with early manifestations and persistent hypercalciuria.
    Girardin E; Favre L; Vallotton MB; Paunier L
    Helv Paediatr Acta; 1986 Aug; 41(3):221-8. PubMed ID: 3759484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of factors influencing the renin-aldosterone system in a patient with Bartter's syndrome.
    Sudan M; Stacy WK; Falls WF
    South Med J; 1979 Jul; 72(7):779-82. PubMed ID: 451681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raised urinary prostaglandins in patient without Bartter's syndrome.
    Nivet H; Grenier B; Rolland JC; Lebranchu Y; Dray F
    Lancet; 1978 Feb; 1(8059):333-4. PubMed ID: 75374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.